Biochip point-of-care device for sepsis diagnostics

To investigate the performance of a new a point-of-care device, it is necessary to run the assays with clinical specimen of healthy and pathological patients. For this the IL-6 levels were first investigated by established clinical systems in two different hospitals and then compared with the new platform. It was possible to resolve the clinical relevant IL-6 levels and a required LOD in the lower pg/ml range was achieved.